How does the BPD work?
The BPD achieves its aims using a two-stage regime involving rigorous evaluation of both biocidal active substances and biocidal products, to ensure they pose no unacceptable risks to people, animals or the environment. Ultimately, only those biocidal products, which contain an active substance, which is included in Annex I of the BPD, will be authorised for use. Active substances have to be evaluated to determine whether they will be included in Annex I. This requires industry to submit data that is evaluated by Member States with decisions over Annex I inclusion being taken at the European level. Industry is charged a fee for this process, which varies dependent on the Member State. Once an active substance has been included in Annex I, Member States can authorise products containing it in individual Member States (providing that any necessary data has been supplied and any conditions put on Annex I inclusion are met). Once a product has been authorised in the first Member State, it
